Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMCOpen access

Substance P enhances the local activation of NK 1 R-expressing c-kit + cardiac progenitor cells in right atrium of ischemia/reperfusion-injured heart

Jeong YM., Cheng XW., Lee KH., Lee S., Cho H., Kim W.

Animal Study with a reported sample of 22 on Cardiovascular Disease, published in BMC Mol Cell Biol (2020) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
BMC Mol Cell Biol (2020)
Reported sample size
22
Source database
Europe PMC
PMID
32517655
PMCID
PMC7285458
DOI
10.1186/s12860-020-00286-x
Citations
5

Abstract (original English)

Background Localization of neurokinin 1 receptor (NK 1 R), the endogenous receptor for neuropeptide substance P (SP), has already been described for the right atrium (RA) of the heart. However, the biological role of SP/NK 1 R signal pathways in the RA remains unclear. Sprague-Dawley rats were randomly divided into 4 groups (n = 22 each); subjected to sham, ischemia/reperfusion-injury (I/R), I/R with 5 nmole/kg SP injection (SP + I/R), and SP + I/R with 1 mg/kg RP67580 injection (RP, a selective non-peptide tachykinin NK 1 R antagonist) (RP/SP + I/R). The left anterior descending coronary artery was occluded for 40 min followed by 1 day reperfusion with SP or SP + RP or without either. After 1 day, both atria and ventricles as well as the heart apexes were collected. Results SP promoted the expression of c-Kit, GATA4, Oct4, Nanog, and Sox2 in only the RA of the SP + I/R rats via NK 1 R activation. In agreement with these observations, NK 1 R-expressing c-Kit + Nkx2.5 + GATA4 + cardiac progenitor cells (CPCs) in the ex vivo RA explant outgrowth assay markedly migrated out from RA 1 day SP + I/R approximately 2-fold increase more than RA 1 day I/R . Treatment of SP promoted proliferation, migration, cardiosphere formation, and potential to differentiate into cardiomyocytes. Using RP inhibitor, NK 1 R antagonist not only inhibited cell proliferation and migration but also reduced

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Heart AtriaMultipotent Stem CellsAnimalsRatsRats, Sprague-DawleyReperfusion InjuryHeart InjuriesDisease Models, AnimalSubstance PReceptors, Neurokinin-1

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research